Medicinova, Inc. (MNOV)
Short-term momentum score is on the low side; smart-money score is below the middle; and price trend score is on the high side.
MNOV scores higher than 61% of the 1,101 tickers we compare it with (Health Care).
As of 9 October 2026, Medicinova, Inc. (MNOV) scores 46 out of 100 on the Market Census six-factor composite, which puts it at the Average score level. The score is made from six named factors: price trend, strength vs the market, company finances, insider trades, market mood and recent momentum. It records what they read on 9 October 2026, and it is not investment advice.
Updated · scores usually change about once a day
Key statistics
Market fields as reported. An em-dash means we hold no value for this ticker — most of the universe has no daily price or volume read.
- Relative volume
- 0.11× 30-day average
- 52-week range
- 1.17 – 3.90
- Market cap
- $163.41M
- Earnings date
- 11 Nov 2026
- Volume
- 69,895
- Avg. volume (30d)
- 645,533
- Open
- 1.54
- Previous close
- 1.54
- Day's range (regular session)
- 1.52 – 1.56
The last trade can be an extended-hours trade, so it can sit outside the regular-session range.
Shown without a peer ranking — we hold no percentile for these yet, so there is nothing here to locate them against.
- Beta
- 0.64
- P/E (TTM)
- —
- EPS (TTM)
- -0.22
Score breakdown · six named factors
Each bar is one part of the score, from 0 to 100. Read what the score means.
Premium data held for MNOV
- 1 SEC Form 4 insider transaction in the last 90 daysPremium
Counts of rows Market Census holds for MNOV. A dash in the factor table above means that factor has no data for this ticker — it is not a locked value. Compare plans
What the score says about MNOV right now
Medicinova, Inc. (MNOV) currently scores 46/100 on the Market Census six-factor composite, at the Average score level. MNOV is -1.30% on the day and -14.61% over five sessions as of the most recent tick. Average sits in the middle. The good and the bad in MNOV's data roughly balance out right now. MNOV's strongest factor is price trend at 76/100 — a strong read on which way the price has been going. The weakest factor is Momentum at 7/100 — well below average recent price moves. Low momentum + high trend often marks a base-building phase rather than a topping pattern.
Generated from the six-factor breakdown above. Changes when the underlying scores do, usually about once a day. More on what the score means.
See MNOV in the scanner
This page is free to read with no account at all. Signing up takes an email and a password: a free account runs the scanner on the top 10 scored rows of any scan, keeps one saved screen, a 5-ticker watchlist, and opens 12 ticker detail pages a day. The card is what starts a 30-day Premium trial — $0 that day, then $19.99/month from day 30, cancel online any time before then — and that is what turns on every matching row instead of the first 10, alerts, the 200-ticker watchlist and recent insider buys (SEC Form 4).
Recent MNOV news
Latest headlines that name Medicinova, one per story, sourced from Market Census’s news feed (Polygon/Massive + Finnhub).
- MediciNova to Participate in the Maxim Growth SummitGlobeNewswire Inc.
- MediciNova Drug Falls Short on Liver Fat Parameter, Stock TumblesYahoo
- MediciNova Shares Fall After Phase 2 Tipelukast Trial Misses Primary EndpointsYahoo
- MediciNova stock tumbles on mixed Phase 2 NAFLD trial dataYahoo
- MediciNova Announces Topline Results from MN-001-NATG-202 Clinical Trial of MN-001 (Tipelukast)GlobeNewswire Inc.
We hide 1 more that told readers to buy or sell, or gave a price target.
Saved snapshot; the news and prices on this page can be an hour old or more.
Similar setups in Health Care right now
Six health care tickers whose composite scores are closest to MNOV’s 46, all within 1 point.
Sorted by closeness to MNOV’s composite score within Health Care. Saved snapshot; can be an hour old or more. Run the full scanner →
Prices delayed about 15 minutes; scores usually change about once a day. Not investment advice — see risk disclosure.